目次

1. General IntroductionMaurice Cassier and Marilena Correa2. Knowledge Generation and Laboratory Capacity Building in the Fight against HIV/Aids in Brazil: Experiences on the Development of a Heat-Stable Formulation Comprising RitonavirCristina Mello R d’Almeida3. Nationalizing Efavirenz: Compulsory Licence, Collective Invention and Neo-Developmentalism in BrazilMaurice Cassier and Marilena Correa 4. The Introduction of Nucleic Acid Tests (Nat) for Blood Screening in the Brazilian Public Healthcare System: Negotiating and Assembling Technologies for the Nationalization of ‘Nat Brasileiro’ (2005–2013)Koichi Kameda5. The Innovation System for the Leishmaniasis Therapy in BrazilMady Barbeitas 6. A Consortium in Times of Crisis: Producing Brazilian Sofosbuvir? (2014–2017)Maurice Cassier and Marilena Correa 7. Health Rights and Intellectual Property Rights: Ministry of Health Prior Consent for Pharmaceutical Patents in BrazilEduardo Guimarães 8. Polymorph Drug Patents and Their Public Health ImpactJaqueline Soares & Eduardo Guimarães 9. Treatment Activism and Intellectual Property of Drugs in BrazilPedro Villela 10. Regulating the Copy Drug Market in Brazil: Testing Generics and Similar Medicines (1999 to 2015)Marilena Correa, Maurice Cassier, Maria Andrea Loyola